Renaissance Technologies’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $627K | Sell |
379,800
-120,107
| -24% | -$198K | ﹤0.01% | 2721 |
|
|
2025
Q1 | $665K | Sell |
499,907
-23,143
| -4% | -$30.8K | ﹤0.01% | 2621 |
|
|
2024
Q4 | $978K | Buy |
523,050
+474
| +0.1% | +$886 | ﹤0.01% | 2512 |
|
|
2024
Q3 | $406K | Buy |
522,576
+38,674
| +8% | +$30K | ﹤0.01% | 2875 |
|
|
2024
Q2 | $363K | Sell |
483,902
-36,198
| -7% | -$27.1K | ﹤0.01% | 2837 |
|
|
2024
Q1 | $551K | Buy |
520,100
+61,420
| +13% | +$65.1K | ﹤0.01% | 2819 |
|
|
2023
Q4 | $482K | Buy |
458,680
+133,680
| +41% | +$140K | ﹤0.01% | 2798 |
|
|
2023
Q3 | $364K | Buy |
325,000
+36,300
| +13% | +$40.7K | ﹤0.01% | 2851 |
|
|
2023
Q2 | $434K | Buy |
288,700
+58,900
| +26% | +$88.5K | ﹤0.01% | 2949 |
|
|
2023
Q1 | $358K | Buy |
229,800
+75,700
| +49% | +$118K | ﹤0.01% | 3044 |
|
|
2022
Q4 | $98K | Sell |
154,100
-180,125
| -54% | -$115K | ﹤0.01% | 3624 |
|
|
2022
Q3 | $445K | Buy |
334,225
+54,726
| +20% | +$72.9K | ﹤0.01% | 2996 |
|
|
2022
Q2 | $620K | Buy |
+279,499
| New | +$620K | ﹤0.01% | 3024 |
|
|
2020
Q4 | – | Sell |
-4,400
| Closed | -$220K | – | 3653 |
|
|
2020
Q3 | $220K | Sell |
4,400
-22,653
| -84% | -$1.13M | ﹤0.01% | 3076 |
|
|
2020
Q2 | $1.25M | Buy |
27,053
+22,108
| +447% | +$1.02M | ﹤0.01% | 2437 |
|
|
2020
Q1 | $226K | Buy |
+4,945
| New | +$226K | ﹤0.01% | 3071 |
|